Preclinical Assets Market
- 2026 年市場規模
- USD 6.8 Bn
- 2033 年預估規模
- USD 9.2 Bn
- 年複合成長率 CAGR
- 8.6%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Preclinical Assets Market, By Service ( Bioanalysis and DMPK studies (In vitro, In-vivo), Toxicology Testing (GLP, Non-GLP), compound management (Process R&D, Custom Synthesis, Asymmetric Synthesis & Others (Scale-up, cGMP, etc.), Safety Pharmacology, Others(Chemistry, etc.)), By Model type (Patient Derived Organoid (PDO) Model, Patient derived xenograft model), By End user (Biopharmaceutical Companies, Government Institutes & Others (Academic and Research institutes) ), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
報告摘要
Preclinical assets consist of various types of services such as Bioanalysis and DMPK (Drug Metabolism and pharmacokinetics) studies, which are further sub segmented into in vitro and in vivo analysis, toxicology testing, which are based on GLP and non GLP (Good Laboratory Practices), compound management process R&D (Research and development), custom synthesis, asymmetric synthesis, and others (Scale-up, cGMP (current good manufacturing practices), safety pharmacology. Preclinical assets have two types of models, patient derived organoid (PDO) model and patient derived xenograft model.
Market Dynamics
Increasing number of service launch in preclinical testing by the key market players is expected to drive growth of the global preclinical assets market during the forecast period. For instance, in July 2020, Skinobs, a cosmetic company, announced the launch of a new preclinical testing platform skinobs, an independent tool which provides a 360-degree vision of in vivo efficacy testing. This platform enables users to identify and select the testing methods depending on various criteria such as
• Test Category: which include analytical tests, content-contenair interaction, ecotoxicity and biodegradability tests, safety tests, UV (Ultra Violet ) tests, etc.
• Claim: which include anti-ageing, anti-pollution, etc.
• Test support: which include cell cultures, 3D skin models, etc.
Similarly, in December 2021, Sirona Medical, a software company, announced the launch of its cloud-native radiology operating system (RadOS) optimizing the use of novel AI (Artificial Intelligence) applications in clinical practice at the 2021 Annual Meeting for Radiological Society of North America (RSNA). The platform was based on the combination of technology and artificial intelligence, which would help augment the intelligence of the physician in clinical practices.
Key features of the study:
• This report provides an in-depth analysis of the global preclinical assets market, market size (USD Bn), and compound annual growth rate (CAGR (%)) for the forecast period: 2026 – 2033, considering 2025 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global preclinical assets market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Eurofins Scientific, ICON plc, WuXi AppTec, Viroclinics Xplore, Medpace, Inc., Charles River Laboratories., Pharmatest Services, PPD Inc., SGS SA (SGS), Intertek Group plc, Labcorp Drug Development, Laboratory Corporation of America, Inc., Crown Bioscience, Comparative Biosciences, Inc., TCG Lifesciences Private Limited., Shanghai Medicilon Inc., Domainex, Absorption Systems, AmplifyBio, and IQVIA
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global preclinical assets market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preclinical assets market
Market Segmentation
• By Service
o Bioanalysis and DMPK studies
In vitro
In-vivo
o Toxicology Testing
GLP
Non-GLP
o compound management
Process R&D
Custom Synthesis
Asymmetric Synthesis & Others (Scale-up, cGMP, etc.)
o Safety Pharmacology
o Others (Chemistry, etc.)
• By Model type
o Patient Derived Organoid (PDO) Model
o Patient derived xenograft model
• By End user
o Biopharmaceutical Companies
o Government Institutes
o Others (Academic and Research institutes)
• By Regional Insights
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Eurofins Scientific
o ICON plc
o WuXi AppTec
o Viroclinics Xplore
o Medpace, Inc.
o Charles River Laboratories.
o Pharmatest Services
o PPD Inc.
o SGS SA (SGS)
o Intertek Group plc
o Labcorp Drug Development
o Laboratory Corporation of America, Inc.
o Crown Bioscience
o Comparative Biosciences, Inc.
o TCG Lifesciences Private Limited.
o Shanghai Medicilon Inc.
o Domainex
o Absorption Systems
o AmplifyBio
o IQVIA
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Service
Market Snapshot, By Model Type
Market Snapshot, By End User
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Technological Advancements
o Regulatory Landscape
o PEST Analysis
4. Global Preclinical Assets Market, By Service, 2026 – 2033, (USD Bn)
o Overview
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o Bioanalysis and DMPK studies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o In vitro
o In-vivo
o Toxicology Testing
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o GLP
o Non-GLP
o Compound Management
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Process R&D
o Custom Synthesis
o Asymmetric Synthesis
o Others (Scale-up and cGMP)
o Safety Pharmacology
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Others (Chemistry, etc.)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Preclinical Assets Market, By Model Type, 2026 – 2033, (USD Bn)
o Overview
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o Patient Derived Organoid (PDO) Model
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Patient derived xenograft model
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Preclinical Assets Market, By End User, 2026 – 2033, (USD Bn)
o Overview
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o Biopharmaceutical Companies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Government Institutes
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Others (Academic and Research institutes)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Preclinical Assets Market, By Region, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2021-2033
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Bn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Bn)
o UK
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Bn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Bn)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026-2033, (USD Bn)
o North Africa
o Central Africa
o South Africa
8. Competitive Landscape
o Heat Map Analysis
o Company Profile
Eurofins Scientific
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
ICON plc
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
WuXi AppTec
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Viroclinics Xplore
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Medpace, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Charles River Laboratories.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Pharmatest Services
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
PPD Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
SGS SA (SGS)
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Intertek Group plc
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Labcorp Drug Development
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Laboratory Corporation of America, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Crown Bioscience
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Comparative Biosciences, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
TCG Lifesciences Private Limited.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Shanghai Medicilon Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Domainex
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Absorption Systems
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
AmplifyBio
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
IQVIA
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About Us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們